Guardant Health

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$201,814
$191,476
$177,235
$168,491
Gross Profit
124,221
116,987
104,814
103,195
EBITDA
-96,480
-91,150
-103,223
EBIT
-107,078
-101,850
-113,935
Net Income
-111,006
-107,754
-102,628
-114,985
Net Change In Cash
201,814
191,476
177,235
168,491
Free Cash Flow
-83,388
-55,258
-99,079
-37,218
Cash
525,540
688,368
1,035,239
1,129,257
Basic Shares
123,994
123,051
122,447
121,712

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$739,016
$563,948
$449,538
$373,653
Gross Profit
449,217
336,896
293,213
250,741
EBITDA
-433,305
-614,910
-359,622
EBIT
-476,186
-650,872
-381,893
Net Income
-436,373
-479,449
-654,588
-384,770
Net Change In Cash
739,016
563,948
449,538
373,653
Cost of Revenue
-348,740
-338,996
Free Cash Flow
-274,943
-345,461
-386,924
-284,052
Cash
525,540
1,133,537
141,647
492,202
Basic Shares
123,994
111,988
102,178
101,314

Earnings Calls

Quarter EPS
2024-12-31
-$0.62
2024-09-30
-$0.88
2024-06-30
-$0.84
2024-03-31
-$0.94